农村和城市骨肉瘤患者之间的等效疾病特异性存活率:SEER数据库的回顾性分析
Kate S Woods1, Mitchell A Taylor1, Peter T Silberstein1,2
1School of Medicine, Creighton University, Omaha, NE 68178, USA.
Current oncology (Toronto, Ont.)
|April 25, 2025
概括
这项研究发现,生活在农村和城市地区的骨髓瘤患者的疾病特异性生存率没有显著差异. 预后因素,而不是位置,似乎影响了骨癌患者的结果.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 生物统计学 生物统计学
背景情况:
- 骨髓瘤是最常见的原发性骨癌.
- 之前的研究表明,转移性疾病的农村和城市差异以及骨髓瘤的整体存活率.
- 关于农村和城市骨髓瘤患者之间疾病特异性生存率 (DSS) 差异的数据有限.
研究的目的:
- 调查农村和城市骨髓瘤患者之间疾病特异性生存率 (DSS) 的差异.
- 根据地理位置分析影响骨髓瘤中DSS的预后因素.
主要方法:
- 利用SEER数据库识别骨髓瘤患者 (2000-2021年).
- 采用了统计分析,包括千平方,卡普兰-梅尔,日志等级测试和逐步的考克斯回归.
- 评估了5年和10年的DSS和多变量危险比率.
主要成果:
- 卡普兰-梅尔分析显示,农村 (55.0%,47.0%) 和城市 (56.0%,51.0%) 患者之间的5年和10年的DSS没有显著差异 (p=0.107).
- 多变量分析证实没有显著的DSS差异 (aHR:1.03;95%CI:0.86-1.24;p=0.757).
- 农村和城市群体之间,转移性疾病在呈现和瘤等级等关键预后因素没有显著差异.
结论:
- 这项研究没有发现基于农村或城市居住的骨髓瘤患者的疾病特异性生存差异.
- 预后因素,而不仅仅是地理位置,可以解释观察到的生存结果.
- 需要进一步的研究来探索农村生活对癌症治疗和结果的其他潜在影响.
相关概念视频
01:21Cancer Survival Analysis
298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298
01:20Comparing the Survival Analysis of Two or More Groups
85
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
85
01:20Actuarial Approach
39
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
39
01:24Kaplan-Meier Approach
55
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
55